{
    "Trade/Device Name(s)": [
        "BioSign\u00ae Flu A+B",
        "BioSign\u00ae Flu A + B",
        "Status Flu A&B"
    ],
    "Submitter Information": "Princeton BioMeditech Corporation",
    "510(k) Number": "K133474",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132465"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "December 10, 2013",
    "Summary Letter Received Date": "November 12, 2013",
    "Submission Date": "November 7, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza type A nucleoprotein antigen",
        "Influenza type B nucleoprotein antigen",
        "Influenza A/Vietnam/1194/2004 (H5N1)",
        "Influenza A/Anhui/01/2005 (H5N1)"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasopharyngeal aspirate/wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Solid phase chromatographic immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BioSign Flu A+B rapid qualitative immunoassay for detection of influenza A and B nucleoprotein antigens including avian H5N1 strains.",
    "Indications for Use Summary": "In vitro rapid qualitative test to detect influenza type A and B nucleoprotein antigens from respiratory specimens to aid in the rapid differential diagnosis of influenza A and B viral infections for professional and laboratory use.",
    "fda_folder": "Microbiology"
}